177 related articles for article (PubMed ID: 38545845)
1. Inconsistency in steroid use as antiemetics in clinical trial protocols involving immune checkpoint inhibitors combined with chemotherapy.
Park SM; Kim YJ; Lee JY
Cancer Med; 2024 Apr; 13(7):e7142. PubMed ID: 38545845
[TBL] [Abstract][Full Text] [Related]
2. Antiemetic medication for prevention and treatment of chemotherapy-induced nausea and vomiting in childhood.
Phillips RS; Friend AJ; Gibson F; Houghton E; Gopaul S; Craig JV; Pizer B
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007786. PubMed ID: 26836199
[TBL] [Abstract][Full Text] [Related]
3. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
Piechotta V; Adams A; Haque M; Scheckel B; Kreuzberger N; Monsef I; Jordan K; Kuhr K; Skoetz N
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012775. PubMed ID: 34784425
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic medication for prevention and treatment of chemotherapy induced nausea and vomiting in childhood.
Phillips RS; Gopaul S; Gibson F; Houghton E; Craig JV; Light K; Pizer B
Cochrane Database Syst Rev; 2010 Sep; (9):CD007786. PubMed ID: 20824866
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of antiemetic practices for prevention of chemotherapy-induced nausea and vomiting (CINV): results of a European oncology nurse survey.
Dielenseger P; Börjeson S; Vidall C; Young A; Jahn P
Support Care Cancer; 2019 Nov; 27(11):4099-4106. PubMed ID: 30783815
[TBL] [Abstract][Full Text] [Related]
6. Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer--an inspection of the evidence base informing clinical decision-making.
Hutton B; Clemons M; Mazzarello S; Kuchuk I; Skidmore B; Ng T
Cancer Treat Rev; 2015 Dec; 41(10):951-9. PubMed ID: 26442474
[TBL] [Abstract][Full Text] [Related]
7. Anti-emetic drugs in oncology: pharmacology and individualization by pharmacogenetics.
Perwitasari DA; Gelderblom H; Atthobari J; Mustofa M; Dwiprahasto I; Nortier JW; Guchelaar HJ
Int J Clin Pharm; 2011 Feb; 33(1):33-43. PubMed ID: 21365391
[TBL] [Abstract][Full Text] [Related]
8. Practice Patterns for Prevention of Chemotherapy-Induced Nausea and Vomiting and Antiemetic Guideline Adherence Based on Real-World Prescribing Data.
Aapro M; Scotté F; Escobar Y; Celio L; Berman R; Franceschetti A; Bell D; Jordan K
Oncologist; 2021 Jun; 26(6):e1073-e1082. PubMed ID: 33555084
[TBL] [Abstract][Full Text] [Related]
9. Risk-benefit of antiemetics in prevention and treatment of chemotherapy-induced nausea and vomiting.
Herrstedt J
Expert Opin Drug Saf; 2004 May; 3(3):231-48. PubMed ID: 15155151
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.
Sutherland A; Naessens K; Plugge E; Ware L; Head K; Burton MJ; Wee B
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012555. PubMed ID: 30246876
[TBL] [Abstract][Full Text] [Related]
11. Cisplatin-Based Therapy and CINV: Optimal Antiemetics During Germ Cell Testicular Cancer Treatment.
Mastrangelo M
Clin J Oncol Nurs; 2018 Apr; 22(2):E31-E36. PubMed ID: 29547608
[TBL] [Abstract][Full Text] [Related]
12. Pooled analysis of combination antiemetic therapy for chemotherapy-induced nausea and vomiting in patients with colorectal cancer treated with oxaliplatin-based chemotherapy of moderate emetic risk.
Shimokawa M; Hayashi T; Nishimura J; Satoh T; Fukunaga M; Matsui R; Tsuji Y; Mizuki F; Kogawa T
BMC Cancer; 2021 Oct; 21(1):1111. PubMed ID: 34656107
[TBL] [Abstract][Full Text] [Related]
13. Is an antiemetic prophylactic treatment needed for patients submitted to consecutive days of 5-fluorouracil? An observational study.
Tumori; 2001; 87(6):379-82. PubMed ID: 11989589
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Adherence to Antiemetic Treatment Guidelines in Patients With Chemotherapy-Induced Nausea and Vomiting in Teaching Hospitals in Tehran.
Nikbakht Z; Rajabi M; Shahrasbi A; Roohi E; Hashemian F
J Cancer Educ; 2021 Oct; 36(5):1022-1029. PubMed ID: 31955393
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of antiemetic in reducing chemotherapy-induced nausea and vomiting in adult patients; An oncology center experience.
Al-Salloum HF; Al-Harbi HE; Abdelazeem A
J Oncol Pharm Pract; 2023 Sep; 29(6):1317-1325. PubMed ID: 36518002
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.
Gottlieb M; Carlson JN; Peksa GD
Cochrane Database Syst Rev; 2022 May; 5(5):CD013860. PubMed ID: 35588093
[TBL] [Abstract][Full Text] [Related]
17. Fixed Combination Antiemetic: A Literature Review on Prevention of Chemotherapy-Induced Nausea and Vomiting Using Netupitant/Palonosetron.
Clark-Snow RA; Vidall C; Börjeson S; Jahn P
Clin J Oncol Nurs; 2018 Apr; 22(2):E52-E63. PubMed ID: 29547597
[TBL] [Abstract][Full Text] [Related]
18. Clinical trials with antiemetic agents in cancer patients receiving chemotherapy.
Penta JS; Poster DS; Bruno S; Macdonald JS
J Clin Pharmacol; 1981; 21(S1):11S-22S. PubMed ID: 6271815
[TBL] [Abstract][Full Text] [Related]
19. Transferability to clinical practice of the results of controlled clinical trials: the case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting. Italian Group for Antiemetic Research.
Ann Oncol; 1998 Jul; 9(7):759-65. PubMed ID: 9739443
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
Jordan K; Kasper C; Schmoll HJ
Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]